Morning Overview on MSN

The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans

Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Neurology Advisor

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Hosted on MSN

The Risks and Benefits of MRI Contrast Dye

You are at the healthcare provider’s office, and they tell you that you need an MRI scan with contrast dye. You might feel a little nervous about having chemicals put into your body. You might wonder, ...
Medscape

Contrast-Enhanced Breast MRI Shows Promise in Identifying High-Risk Lesions That May Not Need Surgery

Contrast-enhanced MRI demonstrated a sensitivity of 91.3% and a specificity of 68.8% in assessing high-risk breast lesions, with the potential to help patients avoid unnecessary surgery, according to ...
Healio

FDA approves Ambelvist MRI contrast agent with lower dose of gadolinium

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...